Rights and permissions
About this article
Cite this article
Optimer aims to improve to access to fidaxomicin. Pharmacoecon. Outcomes News 664, 10 (2012). https://doi.org/10.2165/00151234-201206640-00031
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206640-00031